AR-A014418
SIGMA/A3230 - ≥98% (HPLC), solid
Synonym: N-
CAS Number: 487021-52-3
Empirical Formula (Hill Notation): C12H12N4O4S
Molecular Weight: 308.31
MDL Number: MFCD08277040
Linear Formula: C12H12N4O4S
Product Type: Chemical
assay | ≥98% (HPLC) |
color | off-white to tan |
form | solid |
InChI | 1S/C12H12N4O4S/c1-20-9-4- |
InChI key | YAEMHJKFIIIULI-UHFFFAOYSA |
originator | AstraZeneca |
Quality Level | 100 |
SMILES string | COc1ccc(CNC(=O)Nc2ncc(s2) |
solubility | DMSO: ≥20 mg/mL, clear, light yellow |
H2O: insoluble | |
storage temp. | 2-8°C |
Application: | AR-A014418 has been used as an inhibitor of glycogen synthase kinase 3 (GSK3). |
Biochem/physiol Actions: | Glycogen synthase kinase 3 (GSK3) is a serine/threonine kinase that has been implicated in pathological conditions such as diabetes and Alzheimer′s disease. GSK3 inhibitor, AR-A014418, inhibits GSK3 (IC50 = 104 nM), in an ATP-competitive manner (Ki = 38 nM). AR-A014418 does not significantly inhibit cdk2 or cdk5 (IC50 > 100 μM) or 26 other kinases, demonstrating high specificity for GSK3. |
Features and Benefits: | This compound is featured on the PKB/Akt page of the Handbook of Receptor Classification and Signal Transduction. To browse other handbook pages, click here . |
Features and Benefits: | This compound was developed by AstraZeneca . To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here . |
General description: | AR-A014418 may have chronic pain-relieving properties. In mice having neuropathic pain, this molecule has been shown to have antihyperalgesic effects. AR-A014418 may modulate proinflammatory cytokines and the catecholaminergic and serotonergic pathways. It has also been studied that AR-A014418 inhibits growth of pancreatic cancer cells. |
Packaging: | 5 mg in glass bottle |
Hazard Codes | Xn |
Risk Statements | 22-37/38-41 |
Safety Statements | 26-36/39 |
RIDADR | NONH for all modes of transport |
WGK Germany | WGK 3 |
Purity | ≥98% (HPLC) |
Storage Temp. | 2-8°C |
UNSPSC | 12352200 |